NV-BELKIN
Belkin, a leading consumer electronics brand for 40 years, today introduced four new products across its mobile power and connectivity portfolios, underscoring Belkin innovation, design excellence, dedication to quality, and commitment to building products more responsibly. Belkin is showcasing its newly announced products at CES Unveiled Las Vegas – the official media event of CES 2024.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240107725407/en/
Belkin supercharges into CES 2024 with powerful new product lineup (Photo: Business Wire)
Charging in a snap with Qi2
BoostCharge Pro 3-in-1 Magnetic Stand
Leveraging the new Qi2 standard, this powerful 3-in-1 wireless charger offers perfect alignment and reliable charging for Qi2-enabled devices at 15W, fast charging for Apple Watch Series 7 and later, and optimal charging for wireless earbuds. Built to include an adjustable hinge, users can effortlessly adjust the angle of the phone for optimal viewing while watching videos, reading articles or video chatting. It is made with a minimum 75% post-consumer recycled (PCR) materials.
$149.99 USD
Coming March 2024 to select markets worldwide
BoostCharge Pro Magnetic Power Bank
The Qi2 magnetic power bank delivers up to 15W of power for Qi2-enabled devices on-the-go, without the hassle of cables. It is engineered with an integrated kickstand for propping the phone up while streaming, reading, or chatting, and works with magnetic and MagSafe cases up to 3mm thick. “Power pass-through” allows for charging the power bank and Qi2 device in one simple action via USB-C port. Offered in 5K, 8K and 10K options, consumers can choose the best power bank for their charging needs. Internal housing (excluding cable) of this product is made with a minimum 72% PCR materials.
$59.99, $79.99, $99.99 USD
Coming March 2024 to select markets worldwide
Power-packed and compact with GaN
BoostCharge Pro 4-Port USB-C GaN Charger 200W
The new 4-Port USB-C GaN Wall Charger packs an impressive 200W of power for fast charging up to 4 devices at the same time. It supports high powered laptops and gaming laptops and is engineered with GaN technology and Programmable Power Supply (PPS) to provide efficient power output and smart power allocation, giving connected devices a safe and optimal charge. The 4-Port USB-C GaN Wall Charger declutters the workspace while charging laptops, tablets, phones, smart watches and earbuds simultaneously – no extra power bricks needed. It is compact and power-packed, measured at 92mm x 118.5mm x 35.5mm, and 650g/1.32lbs. The housing (excluding power cord) of this product is made with a minimum 72% PCR materials.
$129.99 USD
Coming March 2024 to belkin.com and select markets worldwide
6-in-1 Core GaN Dock
Belkin is innovating its docks category with the use of GaN to deliver smaller, more efficient, more responsible workspace solutions. Approximately 50 percent smaller1 than other 6-in-1 solutions and highly spec'd to support all essential needs, the Core GaN Dock features 1x HDMI port for high-definition display resolutions up to 4K, 2x USB-A ports for legacy devices, 2x USB-C ports (1 with 96W power delivery), and 1 gigabit ethernet port for secure and reliable Internet connection.
$139.99 USD
Available to order now on belkin.com
Coming soon to select retailers worldwide
Built more responsibly
In line with the company’s commitment to find more responsible ways to build products, Belkin’s newly announced BoostCharge solutions are made with a minimum of 72% PCR materials and sold in plastic-free packaging. One year since Belkin announced its transition to PCR, it has transitioned over 200 products to incorporate PCR, and has replaced 64 metric tons of virgin plastic with PCR materials. Belkin remains committed to its goal of 100% carbon neutrality in its offices and operations (scope 1 & 2 emissions) by 2025 while tackling product level emissions (scope 3).
Media kit is available for download HERE.
About Belkin
Belkin is a California-based accessories leader delivering award-winning power, protection, productivity, connectivity, and audio products over the last 40 years. Designed and engineered in Southern California and sold in more than 100 countries around the world, Belkin has maintained its steadfast focus on research and development, community, education, sustainability and most importantly, the people it serves. From the humble beginnings of a garage in 1980s Southern California to a diverse, global technology company today, we remain forever inspired by the planet we live on, and the connection between people and technology.
1 Based on internal tests against competing non-GaN solutions with power supply unit. Dimensions: 80 x 80 x 48mm; surface area: 6,400mm
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240107725407/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom